NVWM LLC’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-11,322
| Closed | -$710K | – | 480 |
|
2022
Q1 | $710K | Sell |
11,322
-189
| -2% | -$11.9K | 0.23% | 145 |
|
2021
Q4 | $872K | Hold |
11,511
| – | – | 0.27% | 136 |
|
2021
Q3 | $1.29M | Buy |
11,511
+83
| +0.7% | +$9.29K | 0.46% | 60 |
|
2021
Q2 | $1.85M | Buy |
11,428
+321
| +3% | +$52K | 0.66% | 39 |
|
2021
Q1 | $1.35M | Sell |
11,107
-66
| -0.6% | -$8.04K | 0.54% | 50 |
|
2020
Q4 | $1.71M | Buy |
11,173
+242
| +2% | +$37.1K | 0.71% | 45 |
|
2020
Q3 | $915K | Buy |
10,931
+172
| +2% | +$14.4K | 0.43% | 73 |
|
2020
Q2 | $790K | Hold |
10,759
| – | – | 0.43% | 74 |
|
2020
Q1 | $456K | Buy |
10,759
+805
| +8% | +$34.1K | 0.32% | 96 |
|
2019
Q4 | $606K | Sell |
9,954
-329
| -3% | -$20K | 0.36% | 90 |
|
2019
Q3 | $422K | Buy |
+10,283
| New | +$422K | 0.26% | 127 |
|